Search - tctmd.com

Displaying 641 - 660 of 747

Sort: Relevancy | Date

News Conference News

Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk

November 17, 2011

News Conference News

‘Judicious Use’ of DES in Low-Risk Patients Could Save Over $200 Million per Year

November 16, 2011

News Conference News

PRISM Individualized Informed Consent Improves PCI Choice, Experience

November 14, 2011

News Industry News

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

November 13, 2011

News Conference News

Two New SES Show Improvement Over First-Generation Stents

Yael L. Maxwell

November 10, 2011

News Industry News

Rotablation does not improve efficacy of drug-eluting stents in complex calcified coronary lesions

November 10, 2011

News Industry News

Paclitaxel-coated balloon angioplasty demonstrates superior results

November 10, 2011

News Industry News

In patients with diabetes, Cryoplasty post-dilation compared to conventional balloon angioplasty decreases the risk of in-stent restenosis

November 10, 2011

News Industry News

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

November 10, 2011

News Industry News

CryoPlasty® Therapy With Boston Scientific PolarCath™ Dilatation System Reduces Restenosis Rates by Nearly 50 Percent in Peripheral Stenting Procedures

November 10, 2011

News Industry News

Clinical trial of a new dual therapy stent establishes non-inferiority compared to paclitaxel-eluting stent

November 10, 2011

News Industry News

Use of drug-eluting balloons with bare metal stents do not show superiority over drug-eluting stents

November 09, 2011

News Industry News

Tryton Announces Successful Live Case Transmission at TCT Conference in San Francisco

November 09, 2011

News Industry News

OrbusNeich Introduces the Combo™ Dual Therapy Stent at TCT 2011

November 09, 2011

News Industry News

BIOTRONIK Announces Positive Results for Pantera Lux Paclitaxel Releasing Balloon

November 09, 2011

News Industry News

Bayer HealthCare's Cotavance Drug Eluting Balloon With Paccocath Technology Reduced Five-Year Target Lesion Revascularization Rates

November 09, 2011

News Conference News

ZES and SES Equally Effective in Long Lesion Treatment

November 08, 2011

News Conference News

Preclinical Results Promising for Combo Stent

November 08, 2011

News Industry News

OrbusNeich’s Genous Stent Demonstrates Most Rapid Coronary Vessel Healing Compared to Bare Metal and Drug Eluting Stents at 14 Days Post-Implantation

November 08, 2011

News Conference News

Low Event Rates with EES Sustained at 2 Years

November 08, 2011

Advertisement

Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk

‘Judicious Use’ of DES in Low-Risk Patients Could Save Over $200 Million per Year

PRISM Individualized Informed Consent Improves PCI Choice, Experience

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

Two New SES Show Improvement Over First-Generation Stents

Rotablation does not improve efficacy of drug-eluting stents in complex calcified coronary lesions

Paclitaxel-coated balloon angioplasty demonstrates superior results

In patients with diabetes, Cryoplasty post-dilation compared to conventional balloon angioplasty decreases the risk of in-stent restenosis

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

CryoPlasty® Therapy With Boston Scientific PolarCath™ Dilatation System Reduces Restenosis Rates by Nearly 50 Percent in Peripheral Stenting Procedures

Clinical trial of a new dual therapy stent establishes non-inferiority compared to paclitaxel-eluting stent

Use of drug-eluting balloons with bare metal stents do not show superiority over drug-eluting stents

Tryton Announces Successful Live Case Transmission at TCT Conference in San Francisco

OrbusNeich Introduces the Combo™ Dual Therapy Stent at TCT 2011

BIOTRONIK Announces Positive Results for Pantera Lux Paclitaxel Releasing Balloon

Bayer HealthCare's Cotavance Drug Eluting Balloon With Paccocath Technology Reduced Five-Year Target Lesion Revascularization Rates

ZES and SES Equally Effective in Long Lesion Treatment

Preclinical Results Promising for Combo Stent

OrbusNeich’s Genous Stent Demonstrates Most Rapid Coronary Vessel Healing Compared to Bare Metal and Drug Eluting Stents at 14 Days Post-Implantation

Low Event Rates with EES Sustained at 2 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content